Light-Driven Cascade Mitochondria-to-Nucleus Photosensitization in Cancer Cell Ablation

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Nuclei and mitochondria possess unique genetic material, making them prime targets for cancer therapy.
• Existing photosensitizers target either mitochondria or nuclei, but not both in a cascade manner.
• Dual organelle targeting can reduce photosensitizer dosage for maximal therapeutic effect.

Purpose of the Study:

• To develop a novel photosensitizer for dual organelle targeting (mitochondria and nucleus) in cancer cells.
• To investigate a cascade strategy for sequential photosensitization in both organelles.
• To explore enhanced photodynamic cancer cell ablation using a single photosensitizer.

Main Methods:

• Design and synthesis of a functionalized iridium complex (BT-Ir) as a photosensitizer.
• In vitro studies to evaluate BT-Ir's targeting ability and photosensitizing efficacy in cancer cells.
• Microscopy and cellular assays to track BT-Ir translocation from mitochondria to nucleus.

Main Results:

• BT-Ir successfully targets mitochondria and subsequently translocates to the nucleus.
• The compound exhibits potent photodynamic activity in both organelles.
• Sequential targeting leads to efficient and continuous cancer cell ablation.

Conclusions:

• A light-driven, mitochondria-to-nucleus cascade strategy using BT-Ir enables dual organelle cancer cell ablation.
• This approach offers a new paradigm for developing more effective photodynamic cancer therapies.
• The strategy holds promise for reducing photosensitizer requirements and improving treatment outcomes.